Clinical Trial Update: Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 long-term effectiveness and safety study of RWJ-333369 as adjunctive therapy for partial-onset seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• RWJ 333369 (RWJ-333369)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Seizures | Phase 3 | Status: COMPLETED